Surface Pharmaceuticals - Crunchbase Company Profile & Funding

Q: Who invested in Surface Pharmaceuticals?

Surface Pharmaceuticals has 2 investors including Visionary Venture Fund And Flying L Partners.

Q: How much funding has Surface Pharmaceuticals raised to date?

Surface Pharmaceuticals has raised obfuscated.

Overview

Surface Pharmaceuticals

Total Funding

obfuscation

Growth Score

Heat Score

Company Performance Metrics

Score

Trend

About These Metrics

AI Content may contain mistakes and is not legal, financial or investment advice.

Learn more.

Growth Score - The measure of growth based on company activity, operational metrics, and investments

Growth Trend - The change in the growth score over the given time period

Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity

Heat Trend - The change in the heat score over the given time period

Recent Milestones

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

Raised Funding Round

Jan 1, 1970

Lorem ipsum dolor sit amet, consectetur

See more interactive data and historical milestones on desktop for the best experience

About Surface Pharmaceuticals

CB Rank

106849

Surface Pharmaceuticals is an owner and operator of a pharmaceutical company intended to provide ophthalmology products.

Founded

obfuscation

Private

Venture - Series Unknown

California City, California, United States

1-10

surfacepharma.com/

Biopharma

Health Care

Pharmaceutical

Funding Rounds

Venture - Series Unknown

OBF

obfuscation

Series A

OBF

obfuscation

Series A

OBF

obfuscation

Key People

Lou Drapeau: Director
Mark Baum: Director

Details

Legal Name

Surface Ophthalmics, Inc.

Operating Status

Active

Company Type

For Profit

Founders

Mark Baum

About the Company

Surface Pharmaceuticals is an owner and operator of a pharmaceutical company intended to provide ophthalmology products. The company's medicines use topical formulations with the patented Klarity delivery vehicle, designed to protect and rehabilitate the ocular surface, enabling patients with dry eye disease to recover on time and properly.

Predictions & Insights

Growth Insight

See this Growth Insight

Surface Pharmaceuticals is

Lorem

to be growing

Top Contributing Factors

Merger or Acquisition

Growth Prediction

See this Growth Prediction

Top Contributing Factors

Growth Insight

Products & Services

Ophthalmology Drug Candidates

Pharmaceutical products developed for treating ocular surface diseases, intended for regulatory approval and clinical use.

Research & Development

Surface Pharmaceuticals is

obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated

...

Unlock More with Crunchbase Pro

Full access to financial & funding data on unlimited profiles
Export up to 2k results/month for analysis
Track market signals on competitors, products, and R&D
Preview private company insights and predictions

Financials

Company Funding

Funding Rounds

Investors

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown

Funding Rounds

Total Funding Amount

obfuscation

Number of Funding Rounds

Unlock company funding data, including rounds, dates, amounts, and investors.

Announced Date	Transaction Name	Number of Investors	Money Raised	Lead Investors	Funding Type
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown
obfuscated obfuscation	Venture Round - Surface Pharmaceuticals	—	obfuscated obfuscation	—	Venture - Series Unknown

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.

Investor Name	Lead Investor	Funding Round	Partners
Visionary Venture Fund	Yes	Series A - Surface Pharmaceuticals	—
Visionary Venture Fund	Yes	Series A - Surface Pharmaceuticals	—
Visionary Venture Fund	Yes	Series A - Surface Pharmaceuticals	—
Visionary Venture Fund	Yes	Series A - Surface Pharmaceuticals	—
Visionary Venture Fund	Yes	Series A - Surface Pharmaceuticals	—